PTS and dihydropteridine reductase deficiency: The identified mutational spectrum was heterogeneous, with PTPS deficiency being the most frequent (50% of these cases), followed by DHPR deficiency (42.9%), which was associated with the worst clinical course and outcome, including death at an early stage of life.